A severe genotype with favourable outcome in very long chain acyl-CoA dehydrogenase deficiency

Arch Dis Child. 2001 Jan;84(1):58-60. doi: 10.1136/adc.84.1.58.

Abstract

A patient with very long chain acyl-CoA dehydrogenase (VLCAD) deficiency is reported. He had a severe neonatal presentation and cardiomyopathy. He was found to be homozygous for a severe mutation with no residual enzyme activity. Tandem mass spectrometry on dried blood spots revealed increased long chain acylcarnitines. VLCAD enzyme activity was severely decreased to 2% of control levels. Dietary management consisted of skimmed milk supplemented with medium chain triglycerides and L-carnitine. Outcome was good and there was no acute recurrence.

Publication types

  • Case Reports

MeSH terms

  • Acyl-CoA Dehydrogenase, Long-Chain / deficiency*
  • Acyl-CoA Dehydrogenase, Long-Chain / genetics
  • Cardiomyopathies / diet therapy
  • Cardiomyopathies / enzymology*
  • Cardiomyopathies / genetics
  • Follow-Up Studies
  • Homozygote*
  • Humans
  • Infant, Newborn
  • Male
  • Mass Spectrometry
  • Mutation
  • Prognosis

Substances

  • Acyl-CoA Dehydrogenase, Long-Chain